Germany vs Netherlands (Kingdom of the): Percentage of bloodstream infection due to Escherichia coli resistant
Germany
9.4%
in 2022
Netherlands (Kingdom of the)
7.6%
in 2022
Germany rank
44th
Netherlands (Kingdom of the) rank
47th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Germany
- Netherlands (Kingdom of the)
How they compare
Germany currently reports 9.4% against 7.6% in Netherlands (Kingdom of the), a difference of 1.8%.
That makes Germany's figure about 1.2 times Netherlands (Kingdom of the)'s.
Across all 6 years both countries report, Germany has been ahead every year.
Germany ranks 44th and Netherlands (Kingdom of the) ranks 47th of 50 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | Netherlands (Kingdom of the) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 12.0% | 6.9% | 5.1% | Germany |
| 2020s | 9.5% | 7.0% | 2.6% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Germany or Netherlands (Kingdom of the)?
- Germany, at 9.4% against 7.6% in Netherlands (Kingdom of the) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Germany and Netherlands (Kingdom of the)?
- 1.8%, with Germany ahead.
- How many years of comparable data are there for Germany and Netherlands (Kingdom of the)?
- 6 years are reported by both, from 2017 to 2022.
- How do Germany and Netherlands (Kingdom of the) rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Germany ranks 44th and Netherlands (Kingdom of the) ranks 47th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.